General Hospital Psychiatry
Volume 32, Issue 1 , Pages 49-56 , January 2010

Anxiety and mood disorders in narcolepsy: a case–control study

  • H.A. Droogleever Fortuyn, M.D.

      Affiliations

    • Department of Psychiatry, Nijmegen Centre for Evidence-Based Practice, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 24 3613410.
    • ,
  • Martijn A. Lappenschaar, M.S.

      Affiliations

    • Department of Psychiatry, Nijmegen Centre for Evidence-Based Practice, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Joop W. Furer, Ph.D.

      Affiliations

    • Department of Social Medicine, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Paul P. Hodiamont, M.D., Ph.D.

      Affiliations

    • Department of Social Medicine, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • Department of Clinical Health Psychology, Tilburg University, P.O. Box 90153, Tilburg, The Netherlands
    • ,
  • Cees A.Th. Rijnders, M.D., Ph.D.

      Affiliations

    • Department of Social Medicine, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • Institute for Mental Health Care Breburg Group, P.O. Box 770, 5000 AT, Tilburg, The Netherlands
    • ,
  • Willy O. Renier, M.D., Ph.D.

      Affiliations

    • Department of Neurology, Canisius Wilhelmina Ziekenhuis, P.O. Box 9015, 6500 GS Nijmegen, The Netherlands
    • Department of Neurology, Donders Institute for Neuroscience, Radboud University Nijmegen Medical Centre, Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Jan K. Buitelaar, M.D., Ph.D.

      Affiliations

    • Department of Psychiatry, Nijmegen Centre for Evidence-Based Practice, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Sebastiaan Overeem, M.D., Ph.D.

      Affiliations

    • Department of Neurology, Donders Institute for Neuroscience, Radboud University Nijmegen Medical Centre, Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • Sleep Medicine Centre ‘Kempenhaeghe’, P.O. Box 61, 5590 AB, Heeze, The Netherlands

Received 12 May 2009 ,Accepted 31 August 2009.

References 

  1. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry. 1992;49(8):651–668
  2. Haba-Rubio J. Psychiatric aspects of organic sleep disorders. Dialogues Clin Neurosci. 2005;7(4):335–346
  3. Costa e Silva JA. Sleep disorders in psychiatry. Metabolism. 2006;55(10 Suppl 2):S40–S44
  4. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet. 2007;369(9560):499–511
  5. Overeem S, Scammell TE, Lammers GJ. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy. Curr Opin Neurol. 2002;15(6):739–745
  6. Fortuyn HA, Swinkels S, Buitelaar J, et al. High prevalence of eating disorders in narcolepsy with cataplexy: a case–control study. Sleep. 2008;31(3):335–341
  7. Fortuyn HA, Lappenschaar GA, Nienhuis FJ, et al. Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. Gen Hosp Psychiatry. 2009;31(2):146–154
  8. Winsky-Sommerer R, Yamanaka A, Diano S, et al. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci. 2004;24(50):11439–11448
  9. Feng P, Vurbic D, Wu Z, Hu Y, Strohl KP. Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine. J Psychopharmacol. 2008;22(7):784–791
  10. Allard JS, Tizabi Y, Shaffery JP, Manaye K. Effects of rapid eye movement sleep deprivation on hypocretin neurons in the hypothalamus of a rat model of depression. Neuropeptides. 2007;41(5):329–337
  11. Dauvilliers YA, Paquereau J, Bastuji H, Drouot X, Weil JS, Viot-Blanc V. Psychological health in central hypersomnias: the French Harmony Study. J Neurol Neurosurg Psychiatry. 2009;
  12. Vourdas A, Shneerson JM, Gregory CA, et al. Narcolepsy and psychopathology: is there an association?. Sleep Med. 2002;3(4):353–360
  13. Kryger MH, Walid R, Manfreda J. Diagnoses received by narcolepsy patients in the year prior to diagnosis by a sleep specialist. Sleep. 2002;25(1):36–41
  14. American Academy of Sleep Medicine . The International Classification of Sleep Disorders, 2nd edition: diagnostic and coding manual. Westchester (IL): American Academy of Sleep Medicine; 2005;
  15. Hodiamont PP, Rijnders CA, Mulder J, Furer JW. Psychiatric disorders in a Dutch health area: a repeated cross-sectional survey. J Affect Disord. 2005;84(1):77–83
  16. Rijnders CA, van den Berg JF, Hodiamont PP, et al. Psychometric properties of the Schedules for Clinical Assessment in Neuropsychiatry (SCAN-2.1). Soc Psychiatry Psychiatr Epidemiol. 2000;35(8):348–352
  17. Wing JK, Babor T, Brugha T, et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry. 1990;47(6):589–593
  18. Brugha TS, Jenkins R, Taub N, Meltzer H, Bebbington PE. A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Psychol Med. 2001;31(6):1001–1013
  19. Kampman O, Kiviniemi P, Koivisto E, et al. Patient characteristics and diagnostic discrepancy in first-episode psychosis. Compr Psychiatry. 2004;45(3):213–218
  20. Baune BT, Caniato RN, Garcia-Alcaraz MA, Berger K. Combined effects of major depression, pain and somatic disorders on general functioning in the general adult population. Pain. 2008;138(2):310–317
  21. Sours JA. Narcolepsy and other disturbances in the sleep–waking rhythm: a study of 115 cases with review of the literature. J Nerv Ment Dis. 1963;137:525–542
  22. Roy A. Psychiatric aspects of narcolepsy. Br J Psychiatry. 1976;128:562–565
  23. Baker TL, Guilleminault C, Nino-Murcia G, Dement WC. Comparative polysomnographic study of narcolepsy and idiopathic central nervous system hypersomnia. Sleep. 1986;9(1 Pt 2):232–242
  24. Celestino D, Rosini E, Carucci ML, Marconi PL, Vercillo E. Ménière's disease and anxiety disorders. Acta Otorhinolaryngol Ital. 2003;23(6):421–427
  25. Kales A, Soldatos CR, Bixler EO, et al. Narcolepsy-cataplexy: II. Psychosocial consequences and associated psychopathology. Arch Neurol. 1982;39(3):169–171
  26. Krishnan RR, Volow MR, Miller PP, Carwile ST. Narcolepsy: preliminary retrospective study of psychiatric and psychosocial aspects. Am J Psychiatry. 1984;141(3):428–431
  27. Mosko S, Zetin M, Glen S, et al. Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients. J Clin Psychol. 1989;45(1):51–60
  28. Daniels E, King MA, Smith IE, Shneerson JM. Health-related quality of life in narcolepsy. J Sleep Res. 2001;10(1):75–81
  29. Ervik S, Abdelnoor M, Heier MS, Ramberg M, Strand G. Health-related quality of life in narcolepsy. Acta Neurol Scand. 2006;114(3):198–204
  30. Dodel R, Peter H, Spottke A, et al. Health-related quality of life in patients with narcolepsy. Sleep Med. 2007;8(7–8):733–741
  31. Akechi T, Nakano T, Akizuki N, et al. Somatic symptoms for diagnosing major depression in cancer patients. Psychosomatics. 2003;44(3):244–248
  32. Koenig HG, George LK, Peterson BL, Pieper CF. Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am J Psychiatry. 1997;154(10):1376–1383
  33. Brundin L, Petersen A, Bjorkqvist M, Traskman-Bendz L. Orexin and psychiatric symptoms in suicide attempters. J Affect Disord. 2007;100(1–3):259–263
  34. Shin HS, Cho HS, Sung KW, Yoon BJ. Orexin-A increases cell surface expression of AMPA receptors in the striatum. Biochem Biophys Res Commun. 2009;378(3):409–413
  35. Hamlin AS, Newby J, McNally GP. The neural correlates and role of D1 dopamine receptors in renewal of extinguished alcohol-seeking. Neuroscience. 2007;146(2):525–536
  36. Aston-Jones G, Smith RJ, Moorman DE, Richardson KA. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology. 2009;56(Suppl 1):112–121
  37. Schneier FR, Liebowitz MR, bi-Dargham A, Zea-Ponce Y, Lin SH, Laruelle M. Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry. 2000;157(3):457–459
  38. Mathew SJ, Coplan JD, Gorman JM. Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry. 2001;158(10):1558–1567
  39. Mathew SJ, Price RB, Charney DS. Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. Am J Med Genet C Semin Med Genet. 2008;148C(2):89–98

PII: S0163-8343(09)00173-X

doi: 10.1016/j.genhosppsych.2009.08.007

General Hospital Psychiatry
Volume 32, Issue 1 , Pages 49-56 , January 2010

Article Tools